PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects
Status:
Recruiting
Trial end date:
2027-05-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the pharmacokinetics (PK) and safety of
intravenous (IV) pantoprazole in patients 1 to 16 years old who are candidates for acid
suppression therapy.